Bivalent Vaccine Safety For Pregnant Women

The safety of the bivalent vaccine for pregnant individuals has been a topic of discussion among health professionals. According to the Society for Maternal Fetal Medicine, the bivalent vaccine is safe for pregnant individuals and can be administered at any time during pregnancy, including the first trimester. This endorsement includes those who are recently pregnant or lactating. The American College of Obstetrics and Gynecology has recommended COVID-19 vaccines for pregnant and lactating women since July 2021, and studies continue to demonstrate the safety of these vaccines for this vulnerable group. In addition, Pfizer's bivalent RSVpreF vaccine (Abrysvo) is recommended for pregnant individuals between 32 and 36 weeks of gestation to prevent severe lower respiratory tract infections in infants.

Bivalent vaccines are safe for pregnant women in all trimesters

The Society for Maternal Fetal Medicine has stated that bivalent boosters can be administered at any time during pregnancy. The CDC has also recommended that all people aged 12 and older receive the Pfizer or Moderna bivalent COVID-19 booster. The CDC further recommends that pregnant people receive the inactivated influenza vaccine, which is safe in all trimesters of pregnancy.

Pregnant women are at an increased risk of developing severe complications from COVID-19, including needing to be admitted to intensive care, requiring a ventilator, and even dying. Having COVID-19 during pregnancy also raises the risk of preterm birth and other complications, including pregnancy loss. Vaccination is the most effective form of protection against COVID-19, and leading experts have said that the various COVID-19 vaccines are safe and effective for pregnant and breastfeeding women.

The RSV bivalent vaccine has also been proven safe for pregnant women and their infants. In a phase 3 trial, the vaccine's safety and efficacy were evaluated in a double-blind, placebo-controlled, multi-country study. The results showed no notable safety concerns with the vaccine, and it was effective in reducing severe RSV-associated lower respiratory tract infections in infants.

Bivalent vaccines are safe for women who are lactating

Pregnant and lactating women have been recommended to receive a COVID-19 vaccine or series since July 2021 by the ACOG. Studies continue to demonstrate no safety concerns related to COVID-19 vaccines during pregnancy and lactation.

The CDC and other major medical organizations recommend that everyone aged 6 months and older who have already been immunized get a booster shot. The CDC also recommends that those who are pregnant or planning to become pregnant get immunized against COVID-19.

The bivalent vaccines were approved for emergency use authorization by the FDA in August 2022 and were later endorsed by the CDC. The CDC recommends that all people aged 12 and older receive the Pfizer or Moderna bivalent booster at least two months after completing the primary series or at least two months after the last dose of the monovalent booster.

The bivalent vaccine provides protection against the original virus and the Omicron variants BA.4 and BA.5.

Bivalent vaccines are safe for women who are planning to get pregnant

Pregnant women are at an increased risk of developing severe complications from COVID-19, including needing to be admitted to intensive care, requiring a ventilator, and even dying. Having COVID-19 during pregnancy also raises the risk of preterm birth and other complications, including pregnancy loss. Vaccination is the most effective form of protection against COVID-19, and it may also help protect newborns from the virus during their first months of life.

The bivalent vaccine includes two mRNA components of COVID-19: one of the original strain of the virus and the other common between the BA.4 and BA.5 lineages of the Omicron variant. The bivalent vaccine was approved for emergency use authorization by the FDA in August 2022 and later recommended by the CDC. The CDC recommends that all people aged 12 and older receive the Pfizer or Moderna bivalent booster at least two months after completing the primary series or at least two months after the last dose of the monovalent booster.

In addition to COVID-19 vaccines, it is also important for pregnant women to receive the flu vaccine. Pregnant people have historically been at higher risk for flu complications, and the CDC recommends annual influenza vaccination for all adults, including pregnant people and those planning to become pregnant. Pregnant women should receive the inactivated influenza vaccine, which is safe in all trimesters of pregnancy.

Bivalent vaccines can be administered with the flu vaccine

The CDC recommends that all people aged 12 and older receive a bivalent vaccine, and the Society for Maternal Fetal Medicine has endorsed this recommendation for pregnant people. According to the Society, the bivalent vaccine can be administered at any time during pregnancy, including the first trimester. This is in line with the general recommendation that COVID-19 and flu vaccines can be given at the same time, with no need to wait between vaccinations.

Pregnant people are at an increased risk of severe illness from the flu and COVID-19, so it is important to get vaccinated. Vaccination is a safe and effective way to protect both the mother and the baby. In fact, a maternal bivalent RSV pre-fusion F vaccine has been shown to reduce severe RSV-associated lower respiratory tract infections in infants up to 180 days following birth.

While getting multiple vaccines at once may cause temporary reactions such as fatigue, headache, and muscle pain, these symptoms are usually mild and go away quickly. The convenience of getting both vaccines in one visit outweighs the minor side effects, and there is no evidence that co-administration affects the effectiveness of either vaccine.

Bivalent vaccines are recommended by obstetricians

Bivalent vaccines have been found to be safe for both mothers and infants, with no notable safety concerns identified in clinical trials. In a large-scale phase 3 trial, the safety and efficacy of a bivalent vaccine were evaluated in healthy pregnant women with low-risk pregnancies. The vaccine group reported an increase in pain at the injection site, but there were no differences in severe adverse events or side effects between the vaccine and placebo groups. The percentages of adverse events and serious adverse events in infants were also similar between the vaccinated and placebo groups.

Bivalent vaccines offer protection against the original virus strain and specific variants, such as the Omicron BA.4 and BA.5 subvariants. The CDC recommends that individuals aged 12 and older receive a bivalent booster to protect against the evolving virus strains. This recommendation is supported by the Society for Maternal Fetal Medicine, which has endorsed the use of bivalent boosters for pregnant, recently pregnant, and lactating individuals. The Society further states that the bivalent booster can be administered at any time during pregnancy, including the first trimester.

Pregnant individuals are at an increased risk of severe complications from COVID-19, including the need for intensive care, ventilation, and even death. Having COVID-19 during pregnancy also increases the risk of preterm birth and other complications, such as pregnancy loss. Therefore, vaccination is crucial to protecting the health and safety of both the mother and the unborn child. The vaccines help build immunity, reducing the likelihood of developing COVID-19 and resulting in milder symptoms if a breakthrough infection occurs.

In addition to COVID-19 vaccines, obstetricians also recommend that pregnant individuals receive the influenza vaccine. Influenza can cause severe complications during pregnancy, and vaccination is a critical preventive measure. The CDC recommends that all pregnant individuals receive the inactivated influenza vaccine, which is safe during all trimesters of pregnancy.

Frequently asked questions